FDA Inspection 1275317 — Katarzyna Kotulska-Jozwiak
The FDA completed an inspection of Katarzyna Kotulska-Jozwiak on Jul 2, 2025 in Warsaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 2, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warsaw (Poland)
Additional Details
Clinical Investigator (CI)